Rare Complication of Lung Biopsy Results in Patient’s Death

ByMichael Talve, CEO

Updated on

Rare Complication of Lung Biopsy Results in Patient’s Death

Case Overview

This case involves a sixty-five-year-old male who was admitted to the hospital for congestive heart failure. His presenting symptoms included progressive shortness of breath, orthopnea, paroxysmal nocturnal dyspnea, and lower extremity swelling. During the patient’s stay, a five-centimeter mass was found on the left posterior upper lung lobe, along with a collection of fluid along the right lung base that was consistent with a pleural effusion. The radiologist recommended a biopsy because the combination of findings was highly suspicious for malignancy. A CT-guided percutaneous biopsy was performed using a posterior approach, and it was conducted without incident. Shortly after the patient was transferred to the recovery area, however, he went into cardiopulmonary arrest. Because of this, ACLS protocols were initiated. A chest tube was placed and over 4000cc of dark red blood was evacuated. Three units of blood were transfused during the code but the patient did not survive.

Questions to the Pulmonology expert and their responses

Q1

Are the complications described in this summary likely the result of inadequate technique?

There is no real evidence here to suggest that this complication was due to inadequate surgical technique. As with any surgical procedure, complications are possible. Fortunately, major complications due to thin needle aspiration biopsies are fairly uncommon, and when complications do occur, they are generally mild. Nonetheless, if the patient was not on anti-coagulants and the labs values were normal before the procedure then there are no real prior predictors of this rare complication.

About the expert

This highly qualified pulmonary care physician is holds both an M.D. and Ph.D degree, and occupies a high ranking clinical directorship at his current institution. He is extensively published and has been involved with clinical trials and major grant funded research in pulmonary medicine.

Expert headshot

E-005926

Specialties:

About the author

Michael Talve, CEO

Michael Talve, CEO

Michael Talve stands at the forefront of legal innovation as the CEO and Managing Director of Expert Institute. Under his visionary leadership, the Expert Institute has established itself as a vital player in the legal technology arena, revolutionizing how lawyers connect with world-class experts and access advanced legal technology.

Michael's role encompasses a variety of strategic responsibilities, including steering the company's strategic direction to align with the evolving needs of the legal profession, ensuring the delivery of unparalleled intelligence and cutting-edge solutions to legal professionals, and enhancing the capabilities of attorneys in case preparation and execution.

His work has made a significant impact on the legal industry's approach to expert consultation and technological integration, fostering a culture of innovation and excellence within the field. Michael's vision and execution have positioned the Expert Institute as a key facilitator at the intersection of law and technology, empowering legal practitioners to leverage expert insights for optimal case outcomes.

Michael holds a degree from Babson College.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.